Skip to main content
. 2018 Dec 27;40(11):902–910. doi: 10.1093/eurheartj/ehy873

Figure 2.

Figure 2

(A) Early mortality and early pulmonary embolism-related adverse outcome rates in patients with vs. without right ventricular dysfunction. An early pulmonary embolism-related adverse outcome (B) was defined as early death, haemodynamic collapse, and/or recurrent venous thromboembolism. Red dots (with corresponding confidence intervals) represent estimates in the presence of right ventricular dysfunction; blue dots, in its absence. BNP, B-type natriuretic peptide; CTPA, computed tomography pulmonary angiography; NT-proBNP, N-terminal pro-B-type natriuretic peptide; PE, pulmonary embolism; 95% CI, 95% confidence interval.